These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3530455)

  • 21. Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada Clinical Trials Group Study.
    Eisenhauer EA; Maroun JA; Fields AL; Walde PL
    Invest New Drugs; 1987 Dec; 5(4):375-8. PubMed ID: 3436743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
    Nichols WC; Kvols LK; Ingle JN; Edmonson JH; Ahmann DL; Rubin J; O'Connell MJ
    Cancer Treat Rep; 1978 May; 62(5):837-9. PubMed ID: 657166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idarubicin in advanced breast cancer: a phase II study.
    Lionetto R; Pronzato P; Conte PF; Sertoli MR; Amoroso D; Rosso R
    Cancer Treat Rep; 1986 Dec; 70(12):1439-40. PubMed ID: 3466694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
    Budman DR; Ginsberg S; Perry M; Weinberg V; Schein P; Hanson J; Coleman M; Wood W
    Cancer Treat Rep; 1982 Aug; 66(8):1667-8. PubMed ID: 7105058
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
    Carpenter JT; Vogel CL; Wang G; Raney M
    Cancer Treat Rep; 1986 Oct; 70(10):1235-6. PubMed ID: 2428493
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
    Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
    Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
    [No Abstract]   [Full Text] [Related]  

  • 27. 1,2,4-Triglycidylurazol in advanced breast cancer: a trial of the phase II study group of the Association of Medical Oncology, German Cancer Society.
    Wander HE; Berdel WE; Bremer K; Peukert M; Queisser W
    Cancer Treat Rep; 1987 Jan; 71(1):93-4. PubMed ID: 3791274
    [No Abstract]   [Full Text] [Related]  

  • 28. Piperazinedione in metastatic renal carcinoma.
    Pasmantier MW; Coleman M; Kennedy BJ; Eagan R; Carolla R; Weiss R; Leone L; Silver RT
    Cancer Treat Rep; 1977 Dec; 61(9):1731-2. PubMed ID: 340039
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II trial of bisantrene in patients with metastatic melanoma.
    Mackel C; Meyskens FL; Alberts DS
    Cancer Treat Rep; 1986 Aug; 70(8):1037-8. PubMed ID: 3731151
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study on DON in patients with previously treated advanced lung cancer.
    Eagan RT; Frytak S; Nichols WC; Creagan ET; Ingle JN
    Cancer Treat Rep; 1982 Aug; 66(8):1665-6. PubMed ID: 6286122
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
    Campora E; Nobile MT; Sertoli MR; Rosso R
    Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
    [No Abstract]   [Full Text] [Related]  

  • 32. Acivicin. An antitumor antibiotic.
    Poster DS; Bruno S; Penta J; Neil GL; McGovren JP
    Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New 2004 guidelines of the Breast Organ Committee of AGO].
    Krankenpfl J; 2004; 42(3-4):81. PubMed ID: 15311888
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.
    Jones WG; Mattsson W
    Cancer Treat Rep; 1984 Apr; 68(4):675-7. PubMed ID: 6585271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.
    Smith IE; Hedley DW; Powles TJ; McElwain TJ
    Cancer Treat Rep; 1978 Oct; 62(10):1427-33. PubMed ID: 709548
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast.
    Sternberg CN; Yagoda A; Casper E; Scoppetuolo M; Scher HI
    Anticancer Res; 1985; 5(4):415-7. PubMed ID: 4037737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phase II study of 4-demethoxydaunorubicin in metastatic breast neoplasms].
    Lionetto R; Ardizzoni A; Repetto L; Pronzato P; Sertoli MR; Rosso R
    G Ital Chemioter; 1985; 32(1):59-60. PubMed ID: 3868637
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypercalcemic crisis in neoplastic diseases: management with mithramycin.
    Elias EG; Evans JT
    Surgery; 1972 Apr; 71(4):631-5. PubMed ID: 4259864
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study.
    Amrein PC; Coleman M; Richards F; Poulin RF; Bernhardt B; Ginsberg SJ; Green MR; Morrison A; Cortes E; Kiang D; Weinberg V; Wood WC
    Cancer Treat Rep; 1982 May; 66(5):1211-3. PubMed ID: 6896294
    [No Abstract]   [Full Text] [Related]  

  • 40. Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group B.
    Green MR; Vosika G; Propert KJ; Ware JH; Comis R
    Cancer Treat Rep; 1986 Apr; 70(4):539-40. PubMed ID: 3698052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.